Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Phase I Study of Non-Engrafting Allogeneic, Mismatched, Unmanipulated Peripheral Blood Mononuclear Cell Infusions to Treat Poor-Prognosis Acute Myeloid Leukemia

Elizabeth F Krakow, MD MSc, Julie Bergeron, MD, Silvy Lachance, MD, Denis-Claude Roy, MD, Jean-Sebastien Delisle, MD PhD

Blood (2015) 126 (23): 2562.

https://doi.org/10.1182/blood.V126.23.2562.2562

Published: 2015

Journal Articles

A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial

Daniel J. DeAngelo, MD PhD, Kristen Stevenson, MS, Donna S Neuberg, ScD, Lewis B. Silverman, MD, Karen K. Ballen, MD, Julie D. Asch, MD, Yasser Abou Mourad, MD, Kristjan Paulson, MD FRCPC, Matthew D. Seftel, MBChB, FRCP(C), MRCP, David Avigan, MD, Julie Bergeron, MD, Stephen Couban, MD, William Blum, MD, John Storring, MD, Martha Wadleigh, MD, David P. Steensma, MD, Jeffrey Supko, PhD, Stephen E. Sallan, MD, Richard M. Stone, MD

Blood (2015) 126 (23): 80.

https://doi.org/10.1182/blood.V126.23.80.80

Published: 2015

Journal Articles

Superiority of Pediatric Chemotherapy over Allogeneic Hematopoietic Cell Transplantation for Philadelphia Chromosome Negative Adult ALL in First Complete Remission: A Combined Analysis of Dana-Farber ALL Consortium and CIBMTR Cohorts

Matthew D. Seftel, MDMPH FRCPC, Donna Neuberg, ScD, Mei-Jie Zhang, PhD, Hai-Lin Wang, MPH, Julie Bergeron, MD FRCPC, Stephen Couban, MD FRCPC, Daniel J. DeAngelo, MD PhD, Marcos J de Lima, MD, Steven M. Devine, MD, Mary Eapen, MBBS, Mary M. Horowitz, MD MS, Marcelo C. Pasquini, MD MS, J. Douglas Rizzo, MD, Wael Saber, MD MS, Stephen E. Sallan, Brenda M. Sandmaier, MD, Daniel J. Weisdorf, MD

Blood (2014) 124 (21): 319.

https://doi.org/10.1182/blood.V124.21.319.319

Published: 2014

Journal Articles

Acute Promyelocytic Leukemia In Canada: Poor Outcomes In Older Patients Remain

Matthew D. Seftel, MRCP, FRCPC, MPH, Anna Serebrin, MD, Pascal Lambert, MSc, Julie Bergeron, MD, Janeve Everett, MD, Andrea Kew, MD, David Jones, Catherine Meloche, Kristjan Paulson, MD, FRCPC, Mitchell Sabloff, MSc, MD, CM ,FRCP(C), Ismial Sherif, John Storring, MD, Donna Turner, Ph.D.

Blood (2013) 122 (21): 1714.

https://doi.org/10.1182/blood.V122.21.1714.1714

Published: 2013

Journal Articles

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Hiba A Zahreddine, Biljana Culjkovic-Kraljacic, PhD, Sarit Assouline, MD, Abdellatif Amri, Patrick Gendron, M.Sc., Andrea A. Romeo, PhD, Stephen Morris, PhD, James Jaquith, PhD, Gregory Cormack, Eftihia Cocolakis, PhD, Julie Bergeron, MD, Leandro Cerchietti, MD, Brian Leber, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB. Borden, PhD

Blood (2013) 122 (21): 821.

https://doi.org/10.1182/blood.V122.21.821.821

Published: 2013

Journal Articles

A Phase I Combination Study of Ribavirin and Low Dose Cytarabine Arabinoside (ara-C) in M4/M5 Acute Myeloid Leukemia (AML) and AML with High eIF4E,

Sarit Assouline, MD, Biljana Kraljacic-Culjkovic, PhD, Eftihia Cocolakis, PhD, Abdellatif Amri, Julie Bergeron, MD, Rahima Jamal, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB Borden, PhD

Blood (2011) 118 (21): 3606.

https://doi.org/10.1182/blood.V118.21.3606.3606

Published: 2011

Journal Articles

Outcome of Patients with Refractory Acute Leukemia Treated with a Third Induction Chemotherapy Regimen

Vincent Philippe Lavallée, MD, Claude Rondeau, TM, Josée Hébert, MD, Julie Bergeron, MD

Blood (2011) 118 (21): 4305.

https://doi.org/10.1182/blood.V118.21.4305.4305

Published: 2011

Journal Articles

Redefinition of TLX1-Positive T-ALLs.

Julie Bergeron, MD, Isabelle Radford, Pharm., Corinne Millien, Patrick Villarese, Elizabeth A. Macintyre, MD,PhD, Vahid Asnafi, MD,PhD

Blood (2006) 108 (11): 2285.

https://doi.org/10.1182/blood.V108.11.2285.2285

Published: 2006

Journal Articles

Notch1 Mutations in Adult T Lymphoblastic Lymphoma and T-ALL.

Frederic Baleydier, MD, Arnauld Simon, MD, Julie Bergeron, MD, Corinne Millien, Kheira Beldjord, MD, PhD, Stephane Lepretre, MD, Herve Dombret, MD, PhD, Vahid Asnafi, MD, PhD, Elizabeth A. Macintyre, MD, PhD

Blood (2006) 108 (11): 2286.

https://doi.org/10.1182/blood.V108.11.2286.2286

Published: 2006

Journal Articles

Differential Immune Susceptibility of Malignant Versus Normal Tissue Leads to Tumor Rejection without GVH after Adoptive Immunotherapy.

Jean-Sebastien Delisle, MD, FRCPC, Marie-Christine Meunier, MSc, Chantal Barron, MSc, Julie Bergeron, MD, FRCPC, Claude Perreault, MD, FRCPC

Blood (2004) 104 (11): 3047.

https://doi.org/10.1182/blood.V104.11.3047.3047

Published: 2004

Journal Articles

Prevelence of α-Globin Deletions in β-Thalassemia Minor Patients and Differences in Erythrocyte Indices.

Denis Soulieres, MD, MSc, Sylvain Marchand, TM, BSc, Xiaoduan Weng, MD, PhD, Julie Bergeron, MD, Louise Robin, TM, Harold J. Olney, MD

Blood (2004) 104 (11): 3761.

https://doi.org/10.1182/blood.V104.11.3761.3761

Published: 2004

Journal Articles

Prevalence of Alpha-Globin Gene Deletions amongst Patients with Unexplained Microcytosis in a North-American Population.

Julie Bergeron, MD, Xiaoduan Weng, MD, PhD, Louise Robin, TM, Harold J. Olney, MD, CM, Denis Soulières, MD, MSc

Blood (2004) 104 (11): 3762.

https://doi.org/10.1182/blood.V104.11.3762.3762

Published: 2004

NARROW

Phase I Study of Non-Engrafting Allogeneic, Mismatched, Unmanipulated Peripheral Blood Mononuclear Cell Infusions to Treat Poor-Prognosis Acute Myeloid Leukemia

A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial

Superiority of Pediatric Chemotherapy over Allogeneic Hematopoietic Cell Transplantation for Philadelphia Chromosome Negative Adult ALL in First Complete Remission: A Combined Analysis of Dana-Farber ALL Consortium and CIBMTR Cohorts

Acute Promyelocytic Leukemia In Canada: Poor Outcomes In Older Patients Remain

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

A Phase I Combination Study of Ribavirin and Low Dose Cytarabine Arabinoside (ara-C) in M4/M5 Acute Myeloid Leukemia (AML) and AML with High eIF4E,

Outcome of Patients with Refractory Acute Leukemia Treated with a Third Induction Chemotherapy Regimen

Redefinition of TLX1-Positive T-ALLs.

Notch1 Mutations in Adult T Lymphoblastic Lymphoma and T-ALL.

Differential Immune Susceptibility of Malignant Versus Normal Tissue Leads to Tumor Rejection without GVH after Adoptive Immunotherapy.

Prevelence of α-Globin Deletions in β-Thalassemia Minor Patients and Differences in Erythrocyte Indices.

Prevalence of Alpha-Globin Gene Deletions amongst Patients with Unexplained Microcytosis in a North-American Population.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only